<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Marked <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> and <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo> accompanied by <z:mp ids='MP_0006112'>angina</z:mp> and a left <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> occurred in a long-term hemodialysis patient following 5 1/2 weeks of oral treatment with oxymetholone, 100 mg/day, a synthetic <z:chebi fb="3" ids="50113">androgen</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>After <z:chebi fb="3" ids="50113">androgen</z:chebi> therapy was discontinued, over a three-month period, plasma <z:chebi fb="23" ids="18059">lipid</z:chebi> values progressively decreased below pretreatment values, and clinical symptoms disappeared </plain></SENT>
<SENT sid="2" pm="."><plain>During rechallenge with oxymetholone, serum <z:chebi fb="23" ids="18059">lipid</z:chebi> values increased substantially, and the <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> pattern changed from a type IV to a type V </plain></SENT>
<SENT sid="3" pm="."><plain>Detailed <z:chebi fb="23" ids="18059">lipid</z:chebi> studies showed subnormal postheparin lipolytic activity and a fast-migrating pre-beta-<z:chebi fb="1" ids="6495">lipoprotein</z:chebi> in a <z:chebi fb="0" ids="39027">very-low-density lipoproteins</z:chebi> (<z:chebi fb="1" ids="39027">VLDL</z:chebi>) fraction </plain></SENT>
<SENT sid="4" pm="."><plain>Because of the data linking <z:chebi fb="23" ids="18059">lipid</z:chebi> abnormalities to <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and the acceleration of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in long-term hemodialysis patients, great caution should be exercised in administering androgenic steroids to these patients </plain></SENT>
</text></document>